BusinessVascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney DiseaseBy Nasdaq OMXNov 13, 2017, 9:30 PM UTC
BusinessMyriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSight® Test to Improve Mental Health Outcomes for VeteransBy Nasdaq OMXNov 10, 2017, 12:05 PM UTC
BusinessAlpha Pro Tech, Ltd. Announces Financial Results for the Third QuarterBy Nasdaq OMXNov 8, 2017, 1:15 PM UTC
BusinessPressReader brings unlimited newspapers and magazines to millions of Cathay Pacific passengersBy Nasdaq OMXNov 7, 2017, 1:21 AM UTC
BusinessPetIQ, Inc. Reports Third Quarter Fiscal 2017 Financial ResultsBy Nasdaq OMXNov 6, 2017, 9:11 PM UTC
BusinessMyriad Genetics Collaborates with CareFirst BlueCross BlueShield on Coverage with Evidence Development (CED) Study for the Vectra® DA TestBy Nasdaq OMXNov 6, 2017, 12:05 PM UTC
BusinessImage Sensing Systems Introduces Wrong Way Alerting SolutionBy Nasdaq OMXNov 3, 2017, 12:30 PM UTC
